Resultados de la búsqueda 101-110 of 15317 for Huntington's+disease
Giving ascorbic acid and combination chemotherapy may work better at treating lymphoma. In the Clonal Cytopenia of Undetermined Significance (CCUS) Cohort D, we ...
This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...
Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...
The aim of this study is to examine the role of mast cell mediators in children with allergic disorders in a two part study.
The purpose of this study is to evaluate the continued safety and probable benefit of the MID-C system for 5 years post-implantation in Adolescent Idiopathic ...
... disease control during Induction have not improved in recent COG trials. ... Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) ...
... and percent change in levels of ctDNA concentration before and after neoadjuvant therapy. ... (AMP-514) in participants with relapsed or ... and may interfere with ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?